Drugs Containing Excipient (Inactive Ingredient) CARBOXYMETHYLCELLULOSE CALCIUM

Branded drugs containing CARBOXYMETHYLCELLULOSE CALCIUM excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Allergan Inc	SAVELLA	milnacipran hydrochloride	0456-1512	CARBOXYMETHYLCELLULOSE CALCIUM
STAT RX USA LLC	SAVELLA	milnacipran hydrochloride	16590-845	CARBOXYMETHYLCELLULOSE CALCIUM
Rebel Distributors Corp	SAVELLA	milnacipran hydrochloride	21695-650	CARBOXYMETHYLCELLULOSE CALCIUM
Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC	SAVELLA	milnacipran hydrochloride	35356-545	CARBOXYMETHYLCELLULOSE CALCIUM
Genentech Inc	ALECENSA	alectinib hydrochloride	50242-130	CARBOXYMETHYLCELLULOSE CALCIUM	2035-04-24
Unit Dose Services	SAVELLA	milnacipran hydrochloride	50436-9993	CARBOXYMETHYLCELLULOSE CALCIUM

Generic drugs containing CARBOXYMETHYLCELLULOSE CALCIUM excipient

Company	Ingredient	NDC	Excipient
Teva Pharmaceuticals USA, Inc.	cefdinir	0093-3160	CARBOXYMETHYLCELLULOSE CALCIUM
Teva Pharmaceuticals USA, Inc.	pioglitazone	0093-7271	CARBOXYMETHYLCELLULOSE CALCIUM
Eon Labs Inc	cilostazol	0185-0123	CARBOXYMETHYLCELLULOSE CALCIUM
Mylan Pharmaceuticals Inc	sorafenib	0378-1201	CARBOXYMETHYLCELLULOSE CALCIUM
Mylan Pharmaceuticals Inc	candesartan cilexetil and hydrochlorothiazide	0378-3001	CARBOXYMETHYLCELLULOSE CALCIUM
Mylan Pharmaceuticals Inc	candesartan cilexetil	0378-3224	CARBOXYMETHYLCELLULOSE CALCIUM

CARBOXYMETHYLCELLULOSE CALCIUM Market Analysis and Financial Projection

Last updated: February 17, 2026

What Are the Market Dynamics for Carboxymethylcellulose Calcium (CMC-CA)?

The CMC-CA market is influenced by increasing demand in pharmaceutical, food, and industrial sectors. Growing awareness of excipient safety and regulatory shifts toward non-toxic ingredients drive expansion. The pharmaceutical segment dominates, driven by use as a binder, disintegrant, and stabilizer. Food industry uses CMC-CA as a thickener and stabilizer, supported by rising processed food consumption. Industrial applications include paper manufacturing and cosmetics.

Market Drivers

• Rising use of oral solid dosage forms requiring binders and disintegrants.
• Stringent safety standards increasing adoption of biodegradable, non-toxic excipients.
• Growth in processed food consumption globally.
• Expansion of the paper and cosmetics industries needing cellulose derivatives.

Market Challenges

• Fluctuations in raw material prices—primarily cellulose and calcium sources.
• Regulatory hurdles in some jurisdictions regarding excipient safety.
• Competition from alternatives such as sodium carboxymethylcellulose and other binders.

Market Trends

• Development of modified CMC-CA with enhanced stability.
• Increasing adoption in emerging markets, especially Asia-Pacific.
• Regulatory harmonization efforts favoring global distribution.
• Advancements in purification and processing technologies to reduce costs.

Competitive Landscape

Major players include:

• Gelatin and other cellulose derivative manufacturers.
• Multinational chemical companies expanding excipient portfolios.
• Local suppliers in emerging markets responding to regional demand.

Forecast

The CMC-CA market is projected to grow at a compound annual growth rate (CAGR) of approximately 4-6% through 2028. Market value was estimated at around USD 200–250 million in 2022, with Asia-Pacific representing the largest regional share due to high pharmaceutical and processed food demand.

How Is the Financial Trajectory Shaping for CMC-CA?

Revenue Trends

• The global CMC-CA market is forecasted to reach USD 300 million by 2028.
• Revenue growth is driven primarily by the pharmaceutical sector, which accounts for over 50% of the market.
• Food industry use contributes about 25%, with industrial applications making up the remainder.

Investment and R&D

• Increasing investment in R&D aims to develop high-performance, low-cost CMC-CA variants.
• Innovation efforts focus on improving purity, functionality, and sustainability.

Cost Factors

• Raw material prices (cellulose pulp, calcium salts) remain volatile.
• Manufacturing costs are influenced by economies of scale and technological advances.
• Regulatory compliance incurs additional costs, especially for markets with strict standards.

Profitability Outlook

• Larger firms with integrated supply chains benefit from economies of scale.
• Niche suppliers face margins pressure due to price competition.
• Potential profitability hinges on effective cost management, innovation, and expanding into emerging markets.

What Are the Key Takeaways?

• The CMC-CA market is growing modestly but steadily, supported by end-use sectors' expansion.
• Demand is strongest in pharmaceuticals and processed foods, with industrial applications providing secondary growth.
• Future growth depends on raw material costs, regulatory approvals, and technological improvements.
• Competition is fierce among large global players and regional suppliers.
• Forecasts anticipate a CAGR of approximately 4-6%, with the market exceeding USD 300 million by 2028.

What Are the Critical FAQs?

1. What are the primary end-use industries for CMC-CA?
Pharmaceuticals, food processing, paper manufacturing, and cosmetics.

2. How does regulatory environment affect CMC-CA sales?
Regulatory standards dictate permissible purity, safety, and usage labels, influencing market access and product development.

3. Who are the dominant players in the CMC-CA market?
Major firms include FMC Corporation, The Dow Chemical Company, and Acetyl Chemicals, alongside regional manufacturers.

4. What technological trends affect CMC-CA production?
Advances in purification, environmentally friendly synthesis routes, and cost-efficient manufacturing enhance market competitiveness.

5. What risks could hinder market growth?
Raw material price volatility, regulatory restrictions, and substitution by alternative excipients.

---

Sources:

1. Market research reports, 2022–2023.
2. Industry publications on pharmaceutical excipients.
3. Company annual reports on excipient markets.
4. Regulatory agency publications on excipient safety standards.
5. Technological assessments in cellulose derivative manufacturing.